Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Lysogene SA

Start price
Target price
Perf. (%)
€0.21
07.01.23
-
07.01.24
-
08.01.24

Could be worthwhile Investment >10% per year
melinda 
07.01.23 20%
buy
Viatris Inc.

Start price
Target price
Perf. (%)
€11.40
07.01.23
-
07.01.24
-3.86%
08.01.24

fenjal 
07.01.23 50%
sell
Novan Inc

Start price
Target price
Perf. (%)
€1.37
07.01.23
€0.000
07.01.24
-16.52%
21.01.23

nvestor 
07.01.23 50%
sell
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€4.19
07.01.23
€1.00
07.01.24
22.53%
21.01.23

nvestor 
07.01.23 50%
sell
Cytomx Therapeutics Inc

Start price
Target price
Perf. (%)
€2.50
07.01.23
€1.00
07.01.24
-5.60%
21.01.23

mixitrader 
07.01.23 50%
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€4.58
06.01.23
-
06.01.24
-8.48%
08.01.23

thomasw 
06.01.23 50%
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€5.60
06.01.23
-
06.01.24
-29.13%
06.01.23

Could be worthwhile Investment >10% per year
michaelkr 
06.01.23 50%
buy
Cytomx Therapeutics Inc

Start price
Target price
Perf. (%)
€1.73
05.01.23
€3.00
31.12.25
37.80%
06.01.23

Could be very worthwhile Investment >20% year
BiotechBee 
05.01.23 60%
sell
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€50.20
04.01.23
-
04.01.24
-73.01%
02.04.23

thomasw 
04.01.23 50%
sell
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€46.30
04.01.23
-
04.01.24
-59.18%
12.01.23

michaelkr 
04.01.23 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€6.46
04.01.23
€12.00
31.12.25
63.49%
05.05.23

Could be very worthwhile Investment >20% year
BiotechBee 
04.01.23 60%
sell
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€39.20
04.01.23
-
04.01.24
-60.00%
20.01.23

Could be worthwhile Investment >10% per year
Vassago1 
04.01.23 50%
buy
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€24.80
04.01.23
-
04.01.24
-33.71%
22.01.23

bundfuture 
04.01.23 50%
sell
Geron Corp.

Start price
Target price
Perf. (%)
€2.80
04.01.23
-
04.01.24
-29.37%
02.04.23

Probably not worthwhile Investment
Vassago1 
04.01.23 50%
buy
Geron Corp.

Start price
Target price
Perf. (%)
€3.00
04.01.23
-
04.01.24
-22.00%
08.01.23

thomasw 
04.01.23 50%
buy
Geron Corp.

Start price
Target price
Perf. (%)
€2.50
04.01.23
€6.00
31.12.25
38.38%
04.01.23

Could be very worthwhile Investment >20% year
BiotechBee 
04.01.23 60%
buy
Rigel Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€1.27
03.01.23
-
03.01.24
-5.60%
08.01.23

Could be worthwhile Investment >10% per year
bundfuture 
03.01.23 50%
buy
Rigel Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€1.34
03.01.23
€24.00
03.01.24
34.11%
23.01.23

Marianka 
03.01.23 70%
sell
Palisade Bio Inc.

Start price
Target price
Perf. (%)
€3.70
03.01.23
€0.000
03.01.24
-41.62%
23.01.23

Ruckelsbuckel 
03.01.23 70%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.55
03.01.23
-
03.01.24
78.44%
14.05.23

Could be worthwhile Investment >10% per year
bundfuture 
03.01.23 50%
buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€68.08
03.01.23
-
03.01.24
-32.29%
28.12.23

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
fenjal 
03.01.23 50%
buy
Revance Therapeutics Inc.

Start price
Target price
Perf. (%)
€17.50
03.01.23
€30.00
31.12.25
76.00%
05.05.23

Could be very worthwhile Investment >20% year
BiotechBee 
03.01.23 70%
buy
Ocuphire Pharma Inc.

Start price
Target price
Perf. (%)
€3.31
03.01.23
€5.00
31.03.25
-3.24%
10.01.23

Could be very worthwhile Investment >20% year
BiotechBee 
03.01.23 60%
buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€92.04
03.01.23
-
03.01.24
-2.13%
20.03.23

fenjal 
03.01.23 50%
buy
Sorrento Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.05
03.01.23
-
03.01.24
-73.34%
28.03.23

Could be worthwhile Investment >10% per year
melinda 
03.01.23 50%